Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CSL ( (AU:CSL) ) has issued an announcement.
CSL Limited has provided an update on its ongoing on-market share buy-back program for its ordinary fully paid shares. The company reported that a total of 3,852,598 shares had been repurchased prior to the latest trading day, with an additional 61,069 shares bought back on the previous day as part of its daily buy-back activity.
The notification, dated 3 March 2026, forms part of CSL’s regular disclosures to the ASX regarding progress of the buy-back first announced on 20 August 2025. The continued execution of the program indicates an ongoing capital management strategy, which can support earnings per share and signal management’s confidence in the company’s valuation to investors.
The most recent analyst rating on (AU:CSL) stock is a Buy with a A$163.00 price target. To see the full list of analyst forecasts on CSL stock, see the AU:CSL Stock Forecast page.
More about CSL
CSL Limited is a publicly listed company on the ASX, trading under the code CSL and issuing ordinary fully paid shares. The company operates in the healthcare and biotechnology sector, with its shares actively traded and subject to capital management initiatives such as on-market share buy-backs.
YTD Price Performance: -15.00%
Average Trading Volume: 1,124,189
Technical Sentiment Signal: Sell
Current Market Cap: A$71.2B
Learn more about CSL stock on TipRanks’ Stock Analysis page.